Gastric mucosal damage induced by local intra‐arterial administration of Paf in the rat
Open Access
- 31 December 1987
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 93 (1), 222-228
- https://doi.org/10.1111/j.1476-5381.1988.tb11425.x
Abstract
1 A technique for the close-arterial administration of substances to the rat stomach in vivo has been developed. 2 Intra-arterial infusion of platelet-activating factor (Paf, 10–50 ng kg−1 min−1 for 10 min) induced macroscopically assessed damage in the corpus mucosa, characterized as vasocongestion and necrosis. 3 The threshold intra-arterial doses of Paf that induced histologically assessed damage in the antrum and corpus of the stomach (10 and 5 ng kg−1 min−1, respectively) produced minimal systemic hypotension (< 20 mmHg) suggesting a dissociation between these events. 4 Pretreatment with the Paf-antagonist, L-652,731 (2.5 mg kg−1 i.v.) prevented the gastric damage induced by local infusion of Paf. 5 Intravenous infusion of Paf (25 ng kg−1 min−1) did not significantly damage the gastric mucosa, in contrast to the same dose infused locally, yet Paf administered by either route produced a comparable degree of hypotension. Such findings suggest minimal metabolism of Paf during its passage through the gastric circulation. 6 Local intra-arterial infusion of Paf in doses as low as 0.25 ng kg−1 min−1, which had no systemic hypotensive actions, significantly induced gastric damage in the presence of intragastric 20% ethanol. 7 These observations support a local role for Paf in the pathogenesis of gastric irritation and ulceration, such as that observed during endotoxin shock or bacterial infection. The present technique is thus useful for the study of locally administered substances on gastric function and integrity.This publication has 20 references indexed in Scilit:
- Prevention of endotoxin-induced gastrointestinal damage by CV-3988, an antagonist of platelet-activating factorEuropean Journal of Pharmacology, 1986
- Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritantsProstaglandins, 1986
- Campylobacter pyloridis, gastritis, and peptic ulceration.Journal of Clinical Pathology, 1986
- Potent ulcerogenic actions of platelet-activating factor on the stomachNature, 1986
- Platelet activating factor intravenous infusion in rats stimulates vascular lysosomal hydrolase secretion independent of blood neutrophilsBiochemical and Biophysical Research Communications, 1984
- Involvement of leukotrienes and PAF-acether in the increased microvascular permeability of the rabbit retinaInflammation Research, 1984
- Paf‐acether (platelet‐activating factor) increases microvascular permeability and affects endothelium‐granulocyte interaction in microvascular bedsActa Physiologica Scandinavica, 1983
- Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogsEuropean Journal of Pharmacology, 1983
- Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: Evidence for a platelet independent mechanismImmunopharmacology, 1982
- BACKGROUND AND PRESENT STATUS OF RESEARCH ON PLATELET‐ACTIVATING FACTOR (PAF‐ACETHER)Annals of the New York Academy of Sciences, 1981